Fax Name: Sarah Dolezal, ARNP Phone: is Fax: Address: Bruce W. Moskowitz, M.D 1411 North Flagler Dr, Suite 7100 West Palm Beach, FL 33401 To: Lesle 4 # of pages: + Regarding Messages: NOTE: This fax may contain confidential information which is intended only for the use of the person(s) named above. if you are not the intended recipient, you are hereby advised that any disclosure, copying, distribution or the taking of any action in reliance on the contents of this information is prohibited. If you have received this transmission in error, please notify the sender. Thank You. EFTA00282998

--=PAGE_BREAK=--

Report Status: Partial (@) Quest “P =! Diagnostics EPSTEIN, JEFFREY EPSTEIN, JEFFREY Specimen: TM037241L Client #: 78300020 56W5265 Requisition; 0000315 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 63 BRUCE MOSKOWITZ, MD Collected: 11/25/2016 Aan: NATIONWIDE ACCOUNT 561.366.0084 Received: 11/25/2016 / 20:16 EST 1411 N FLAGLER DR STE 7100 Patient ID; 19530120MJE Reported: 11/28/2016 / 18:47 EST WEST PALM BEACH, FL 33401-3418 Health ID: 8573003290851249 Test Name In Range Qut Of Range Reference Range Lab PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS PROTEIN, TOTAL, SERUM Mt PROTEIN, TOTAL 7.2 6.1-8.1 g/dL PROTEIN ELECTROPHORESIS TP ALBUMIN 4.3 3.8-4.8 g/dL ALPHA 1 GLOBULIN 0.3 0.2-0.3 g/dL ALPHA 2 GLOBULIN 0.7 0.5-0.9 g/dL BETA 1 GLOBULIN 0.6 0.4-0.6 g/dL BETA 2 GLOBULIN 0.3 0.2-0.5 g/dL GAMMA GLOBULIN 1.0 0.81.7 g/dL INTERPRETATION Normal Electrophoretic Pattern LIPID PANEL CHOLESTEROL, TOTAL 143 125-200 ma/dL MI HDL CHOLESTEROL 30 L > OR = 40 mg/dL MI TRIGLYCERIDES 197 # <150 mg/d MI LDL-CHOLESTEROL 74 <130 mg/d (calc) MI Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. CHOL/HDLC RATIO 4.8 < OR = 5.0 (cale) MI NON HDL CHOLESTEROL 113 mg/di (calc) MI Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.3 mg/L TP Lower relative cardiovascular xisk according to AHA/CDOC guidelines. For ages >17 Years: hs-CRP mg/L Risk According to ABA/CDC Guidelines <1.0 Lower relative cardiovascular risk. 1.0-3.0 Average relative cardiovascular risk. 3.1-10.0 Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. >10.0 Persistent elevation, upon retesting, May be associated with infection and inflammation. HOMOCYSTEINE 15.248 <11.4 umol/L MI Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and CLIENT SERVICES: 866.697.8378 SPECIMEN: TM037241L PAGE 1 OF 5 Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quert Diagnostics. EFTA00282999

--=PAGE_BREAK=--

@) Quest Report Status: Partial ©! diagnostics EPSTEIN, JEFFREY EPSTEIN, JEFFREY DOB: 01/20/1953 AGE; 63 Gender: M Patient ID: 19530120MIE Health ID: 8573003290851249 Specimen; TM037241L Collected: 11/25/2016 Reecived: 11/25/2016 / 20:16 EST Reported: 11/28/2016 / 18:47 EST Client #; 78300020 MOSKOWITZ, BRUCE W Test Name In Range Out Of Range Reference Range Lab exposure to nitrous oxide. COMPREHENSIVE METABOLIC MI PANEL GLUCOSE 99 65-95 mg/dL Fasting reference interval UREA NITROGEN (BUN) 268 7-28 mg/dL CREATININE 0.94 0.70-1.25 mg/dL For patients >49 yesrs of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN 86 > OR = 60 mL/min/1.73m2 e@GFR AFRICAN AMERICAN 100 > OR = 60 mL/min/1.73m2 BUN/CREATININE RATIO 28H 6-22 (calc) SODIUM 138 135-146 mmol/L POTASSIUM 4.6 3.5-5.3 mmol/L CHLORIDE 106 98-110 mmol/L CARBON DIOXIDE 20 20-31 mmoi/L CALCIUM 9.9 8.6-10.3 mg/dL PROTEIN, TOTAL 7.2 6.1-8.1 g/d ALBUMIN 4.5 3.6-5.1 g/dL GLOBULIN 2.7 1.9-3.7 g/dL (cale) ALBUMIN/GLOBULIN RATIO 1.7 1.0-2.5 (calc) BILIRUBIN, TOTAL 1.1 0.2+1.2 mg/dL ALKALINE PHOSPHATASE $3 40-115 U/L AST 19 10-35 U/L ALT 20 9-46 U/L HEMOGLOBIN Alc 5.98 <5.7 & of total Hgb MI According to ADA guidelines, hemoglobin Ale <7.0% represents optimal control in non-pregnant diabetic patients. Different metrics may apply to specific patient populations. Standards of Medical Care in Diabetes-2013. Diabetes Care. 2013;36:s11-s66 For the purpose of screening for the presence of diabetes <5.7% Consistent with the absence of diabetes 5.7-6.4% Consistent with increased risk for diabetes (prediabetes) >or=6.54 Consistent with diabetes This assay result is consistent with an increased risk of diabetes. Currently, no consensus exists for use of hemoglobin Alc for diagnosis of diabetes for children. URIC ACID 8.7 E 4.0-8.0 mg/dL MI Therapeutic target for gout patients: <6.0 mg/dL TSH 2.33 0.40-4.50 mIU/L MI T4 (THYROXINE), TOTAL 7.4 4.5-12.0 meg/dL MI FREE T4 INDEX (T7) 2.4 1.4-3.8 T3 UPTAKE 32 22-35 & MI PARTIAL THROMBOPLASTIN MI CLIENT SERVICES: 866.697.8378 SPECIMEN: TM037241L PAGE 2 OF § Quest, Quest Diagnostics, the associated logo ond all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics, EFTA00283000

--=PAGE_BREAK=--

rt Status: Parti (@) Quest Report Status: Partial ef Diagnostics EPSTEIN, JEFFREY Client Taformation EPSTEIN, JEFFREY Client #; 78300020 MOSKOWITZ, BRUCE W DOB: 61/20/1953 AGE: 63 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name TIME, ACTIVATED TM037241L Collected; 11/25/2016 Received: 11/25/2016 / 20:16 EST Reported: 11/28/2016 / 18:47 EST In Range Out Of Range Reference Range Lab 28 22-34 sec This test has not been validated for monitoring unfractionated heparin therapy. For testing that is validated for this type of therapy, please refer to the Heparin Anti-Xa assay (test code 30292). For additional information, please refer to http: //education.QuestDiagnostics.com/faq/fAQ15$ (This link is being provided for informational/educational purposes only.) PROTHROMBIN TIME-INR MI INR 1.1 Reference Range 0.9-1. Moderate-intensity Warfarin Therapy 2.0-3. Higher-intensity Warfarin Therapy 3.0-4. oor PT 10.8 $.0-11.5 sec For more information on this test, go to: http: //education.questdiagnostics.com/fag/FAQ104 SED RATE BY MODIFIED MI WESTERGREN 6 < OR = 20 mm/h CBC (INCLUDES DIFF/PLT) MI WHITE BLOOD CELL COUNT 6.4 3.8-10.8 Thousand/ub RED BLOOD CELL COUNT 5.10 4.20-5.80 Million/uL HEMOGLOBIN 14.5 13.2-17.1 g/dt HEMATOCRIT 44.0 38.5-50.0 % Mev 86.2 80.0~-100.0 £1, MCH 28.4 27.0=33.0 pg MCEC 33.0 32.0-36.0 ¢/at RDW 14.0 11.0-15.0 & PLATELET COUNT 277 140-400 Thousand/uL MPV 8.0 7.5-11.5 £L ABSOLUTE NEUTROPHILS 3236 1500-7800 cells/uL ABSOLUTE LYMPHOCYTES 2221 850-3900 ceils/vL ABSOLUTE MONOCYTES 454 200-950 cells/uL ABSOLUTE EOSINOPHILS 390 15-500 celis/ul ABSOLUTE BASOPHILS 38 0-200 cells/ut NEUTROPHILS 51.5 * LYMPHOCYTES 34.7 $ MONOCYTES Ti $ EOSINOPHILS 6.1 s BASOPHILS 0.6 % URINALYSIS, COMPLETE MI COLOR YELLOW 7 YELLOW APPEARANCE CLEAR CLEAR SPECIFIC GRAVITY 1.023 1.001*1.035 Py < OR ~ 5.0 5.0-8.0 GLUCOSE NEGATIVE NEGATIVE BILIRUBIN NEGATIVE NEGATIVE KETONES NEGATIVE NEGATIVE OCCULT BLOOD TRACE NEGATIVE PROTEIN NEGATIVE NEGATIVE NITRITE NEGATIVE NEGATIVE CLIENT SERVICES: 866.697.8378 SPECIMEN; TM037241L PAGE 3 OF 5 Quent, Quest Dingnostics, the associated logo and all associnted Quest Diagnostics marks are the trademarks of Quest Diagnostics, EFTA00283001

--=PAGE_BREAK=--

Report Status; Partial (@) Quest "STEIN | = Diagnostics EPSTEIN, JEFFREY EP: N, JE Client #; 78300020 STEL FFREY MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 63 Gender; M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen; TM037241L Collected: 11/25/2016 Received: 11/25/2016 / 20:16 EST Reported; 11/28/2016 / 18:47 EST Test Name In Range Out Of Range Reference Range Lab LEUKOCYTE ESTERASE NEGATIVE NEGATIVE WBC NONE SEEN < OR = 5 /HPF RBC NONE SEEN < OR = 2 /HPF SQUAMOUS EPITHELIAL CELLS NONE SEEN < OR = 5 /HPF BACTERIA NONE SEEN NONE SEEN /HPF HYALINE CAST NONE SEEN NONE SEEN /LPF VITAMIN B12 496 200-1100 pg/mL MI C-REACTIVE PROTEIN <0.10 <0.80 mg/dL MI Please be advised that patients taking Carboxypenicillins May exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. PROLACTIN 3.0 2.0-18.0 ng/mL MI TESTOSTERONE, TOTAL MI MALES (ADULT), Ia TESTOSTERONE, TOTAL, MALES (ADULT), IA 185 L 250-827 ng/dL Men with clinically significant hypogonadal symptoms and testosterone values repeatedly less than approximately 300 ng/dL may benefit from testosterone treatment. after adequate risk and benefits counseling. in hypogenadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy o£ immunoassay at levels below 250 ng/dL. This test code (15383) must be collected in a red-top tube with no gel. Two morning (8-10 a.m.) specimens obtained on different days are recommended by The Endocrine Society for screening for hypogonadism. PSA, TOTAL 0.5 : < OR - 4.0 ng/mL MI This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. CLIENT SERVICES: 866.697.8378 SPECIMEN: TM037241L PAGE 4 OF 5 Quest, Quest Diagnostics, the associated Ingo and all associated Quest Diagnostics marke are the trademarks of Quest Diagnastics, EFTA00283002

--=PAGE_BREAK=--

Report Status: Partial @i Quest P s: Partial ©! Diagnostics EPSTEIN, JEFFREY Patient Information EPSTEIN, JEFFREY Client Information Client #; 78300020 MOSKOWITZ, BRUCE W | Specimen Information Specimen: 7TM037241L Collected: 11/25/2016 DOB: 01/20/1953 AGE: 63 Received: 11/25/2016 / 20:16 EST Gender; M Reported; 11/28/2016 / 18:47 EST Patient ID: 19530120MIE Health ID: 8573003290851249 Test Name Reference Range Vitamin D Status 25-OH Vitamin D: Deficiency: <20 ne/mL Insufficiency: 20 = 29 ng/mL Optimal: > or = 30 ng/mL For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssvreD (TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92868 (patients >2yrs). For more information on this test, go te: http: //education. questdiagnostics,com/faq/FAQLE3 (This link is being provided for informational/educational purposes only.) Physician Comments: mn Eee. PENDING TESTS: CALCIUM, IONIZED IMMUNOFIXATION, SERUM MERCURY, BLOOD PERFORMING SITE: Mi QUEST DIAGNOSTICS-MIAMI, 1920 COMMERCE PARKWAY, MIRAMAR, FL 3302523938 Laharstory Direstor: GLEN L. HORTIN MD PHD, CLIA: 1000277334 TP QUEST DIAGNOSTICS-TAMPA, 4225 E. FOWLER AVE, TAMPA, FL 33617-2026 Laboralory Director: GLEN | HORTIN.MD,PHD, CLIA: 100029! 120 CLIENT SERVICES: 866.697.8378 SPECIMEN: TM03724iL PAGE 5 OF S$ Quest, Quest Dingnostics, the associated loge and all associated Quest Dingnostics marks are the trademarks of Quest Diagnostics. EFTA00283003

--=PAGE_BREAK=--

Report Status: Final (@) Quest : " =! Diagnostics’ EPSTEIN, JEFFREY Specimen Taformation EPSTEIN, JEFFREY Specimen: TM037242L Client #: 78300020 S6W5265 Requisition: 0000314 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 63 BRUCE MOSKOWITZ, MD Gender; M Collected: 11/25/2016 Attn: NATIONWIDE ACCOUNT Phone: 561.366.0084 Received: 11/25/2016 /20:23 EST 411 WFLAGLER DR STE 7000 Patient TD: 19530120MJE Reported: 11/28/2016 / 11:05 EST WEST PALM BEACH, FL 33401-3418 Health ID; 8573003290851249 Test Name In Range Out Of Range Reference Range Lab PTH, INTACT AND CALCIUM PTH, INTACT MI PARATHYROID HORMONE, INTACT , J7Aa 14-64 pg/mL Interpretive Guide Intact PTH Caleium Normal Farathyroid Normal Norma], Hypoparathyroidism Low or Low Normal Low Hyperparathyroidism Primary Normal or High High Secondary Righ Normal or Low Tertiary High BKigh Non-Parathyroid Hypercalcemia Low or Low Normal High CALCIUM 9.7 8.6-10.3 me/dL MI PERFORMING SITE: Mi QUEST DIAGNOSTICS-MIAMI, 10200 COMMERCE PARKWAY, MIRAMAR, FL 3025-2934 Laborutory Dircetne: GLEN L HORTIN MD PHD, CLIA: 1On2? 7994 CLIENT SERVICES: 866.697.8378 SPECIMEN: TM037242L PAGE | OF | Quert, Quest Diagnostics, the associated loge and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics, EFTA00283004